Evidence map›Paper›PMID 32704349›Full record

ArticleF1000Research2019

Gut microbiome-Mediterranean diet interactions in improving host health.

Ravinder Nagpal, Carol A Shively, Thomas C Register, Suzanne Craft, Hariom Yadav

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in F1000Research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05469997 (Ketogenic Diet Interventions in Parkinson's Disease), which is not on this map. Cited by 97 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
97citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05469997 nacompletednot on this mapstarted 2023, after this paper: background citation

Ketogenic Diet Interventions in Parkinson's Disease: Safeguarding the Gut Microbiome

TypeinterventionalSponsorUniversity of British ColumbiaRan2023 to 2024Enrolled52ConditionsParkinson DiseaseArmsMediterranean-Ketogenic Diet, Mediterranean diet supplemented with medium-chain triglyceride oil
3 · Its place in the literature

Who cites it

97 citing papers in PubMed, 1 synthesis or guideline pooled it, 153 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Review
  6. Review
  7. Gut microbiota: contributing to high CVD prevalence in people living with schizophrenia?European archives of psychiatry and clinical neuroscience · 2026
    Review
  8. Gut-brain axis in health and brain disease.Chinese medical journal · 2026
    Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review

37 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ravinder NagpalDivision of Internal Medicine - Molecular Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, 27101, USA.
Carol A ShivelyDepartment of Pathology - Comparative Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, 27101, USA.
Thomas C RegisterDepartment of Pathology - Comparative Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, 27101, USA.
Suzanne CraftDepartment of Gerontology and Geriatric Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, 27101, USA.
Hariom YadavDivision of Internal Medicine - Molecular Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, 27101, USA.ORCID 0000-0003-4504-1597
Atrium Health Wake Forest Baptist · US

Funding

Wake Forest Claude D. Pepper OAIC - RenewalP30AG021332 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Jamie Nicole Justice · 2002 to 2026
$36.4M
Wake Forest Clinical and Translational Science AwardUL1TR001420 · NCATS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ARD, JAMY D, FOLEY, KRISTIE L · 2015 to 2023
$32.3M
Wake Forest Alzheimer's Disease Core CenterP30AG049638 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI RAPP, STEPHEN R · 2016 to 2020
$12.2M
Dietary Mitigation of Psychosocial Stress Effects on CVD Risk R01HL087103 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI SHIVELY, CAROL A. · 2007 to 2017
$6.0M
Exercise Intolerance in Older HFPEF PatientsR01AG018915 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI KITZMAN, DALANE W · 2001 to 2019
$5.2M
Effects of Western and Mediterranean Diets on Metabolic and Neuropathologic Risk Factors for Alzheimer's Disease in Nonhuman PrimatesRF1AG058829 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI CRAFT, SUZANNE, SHIVELY, CAROL A. · 2018 to 2018
$2.8M
Beta-cell Function and Cognition in the Restoring Insulin Secretion (RISE) StudyR01DK099164 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI CRAFT, SUZANNE · 2013 to 2016
$2.0M
Social Stress, Diet. and Primate Monocyte Programming in Cardiovascular RiskR01HL122393 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI REGISTER, THOMAS COSTIN, SHIVELY, CAROL A. · 2015 to 2018
$2.0M
NCATS NIH HHS UL1 TR001420NHLBI NIH HHS R01 HL087103NHLBI NIH HHS R01 HL122393NIA NIH HHS P30 AG021332NIA NIH HHS P30 AG049638NIA NIH HHS R01 AG018915NIA NIH HHS RF1 AG058829NIDDK NIH HHS R01 DK099164
6 · The paper itself

Abstract

The gut microbiota plays a fundamental role in host health and disease. Host diet is one of the most significant modulators of the gut microbial community and its metabolic activities. Evidence demonstrates that dietary patterns such as the 'Western diet' and perturbations in gut microbiome (dysbiosis) have strong associations with a wide range of human diseases, including obesity, metabolic syndrome, type-2 diabetes and cardiovascular diseases. However, consumption of Mediterranean-style diets is considered healthy and associated with the prevention of cardiovascular and metabolic diseases, colorectal cancers and many other diseases. Such beneficial effects of the Mediterranean diet might be attributed to high proportion of fibers, mono- and poly-unsaturated fatty acids, antioxidants and polyphenols. Concurrent literature has demonstrated beneficial modulation of the gut microbiome following a Mediterranean-style diet in humans as well as in experimental animal models such as rodents. We recently demonstrated similar positive changes in the gut microbiome of non-human primates consuming a Mediterranean-style diet for long term (30 months). Therefore, it is rational to speculate that this positive modulation of the gut microbiome diversity, composition and function is one of the main factors intermediating the health effects of Mediterranean diet on the host. The present perspective discusses the evidences that the Mediterranean diet induces gut microbiome modulation in rodents, non-human primates and human subjects, and discusses the potential role of gut microbiota and microbial metabolites as one of the fundamental catalysts intermediating various beneficial health effects of Mediterranean diet on the host.

Indexed as

Diet, HealthyDiet, MediterraneanGastrointestinal MicrobiomeAnimalsCardiovascular DiseasesDiabetes Mellitus, Type 2DysbiosisHumansMetabolic SyndromeObesityfibergut microbiotaMediterranean dietmonkeynon-human primateshort-chain fatty acidswestern diet

Identifiers

PMID32704349
PMCPMC7359750
OpenAlexW2946719617

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.